Clinical Trial Update: 18F-Sodium Fluoride (18F-NaF) PET-CT Imaging to Identify Vulnerable Plaques in Patients With Diabetes [NA]

View source ↗

Summary

Clinical trial evaluating 18F-NaF PET-CT imaging to identify vulnerable plaques in patients with diabetes; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Complications of Diabetes Mellitus

Snippet

Sponsor: University of Alberta | Conditions: Atherosclerosis, Complications of Diabetes Mellitus | NA | Status: COMPLETED